Ranbaxy Estimates Production Capacity For Generic Tamiflu
This article was originally published in The Pink Sheet Daily
Executive Summary
The generics firm said it will be capable of producing the Roche antiviral’s active pharmaceutical ingredient at a rate of 22 tons per annum.